Core Viewpoint - The new policy document issued by the Ministry of Commerce and nine other departments aims to enhance the role of retail pharmacies in China, transforming them into "health stations" that provide professional services, health promotion, and emergency supply functions [1][2]. Group 1: Policy Objectives - The document outlines 18 measures to support pharmacies in improving pharmaceutical service capabilities, optimizing the purchasing experience, participating in centralized drug procurement, and establishing payment guarantee systems [2][3]. - The retail pharmaceutical market in China has been expanding, with sales increasing from 2.41 trillion yuan in 2020 to an expected 2.95 trillion yuan in 2024 [3]. Group 2: Empowerment and Quality Improvement - The policy allows retail pharmacy chains to establish their own pharmaceutical service platforms, enabling licensed pharmacists to provide remote prescription reviews and medication guidance [3]. - It encourages the optimization of the drug business license application process and supports the sale of innovative drugs and reference preparations through retail pharmacies [4]. Group 3: Accountability and Community Engagement - The policy emphasizes the need for retail pharmacies to enhance emergency services and encourages large pharmacy chains to establish dynamic demand forecasting and low inventory warning mechanisms [4]. - It promotes collaboration between pharmacies and community organizations to provide health care services tailored to the elderly, disabled, and children, further expanding the role of pharmacies as health stations [4][6]. Group 4: Market Competition and Collaboration - The document stresses the importance of fair competition in the industry and advocates for deep cooperation between pharmaceutical manufacturers and large distribution companies to regulate drug pricing [5].

Core Viewpoint - The Ministry of Commerce and nine other departments have jointly issued opinions to promote high-quality development in the pharmaceutical retail industry, focusing on five key measures [1]. Group 1: Key Measures - The five key measures include improving pharmaceutical services, innovating health services, strengthening emergency services, optimizing industry structure, and regulating industry order [1]. Group 2: Industry Structure Optimization - The opinions support the merger and reorganization of retail pharmacies, encouraging horizontal mergers and acquisitions among pharmaceutical retail enterprises [1]. - Local governments are encouraged to optimize the business environment, particularly for integrated chain or standalone pharmacies, by streamlining the application process for pharmaceutical business licenses [1]. - For changes in medical insurance qualifications, the original qualifications are allowed to continue and be used until the new qualifications are officially opened, at which point the original qualifications can be canceled [1]. Group 3: Industry Transformation - The pharmaceutical retail industry in China is at a critical stage of innovative transformation, requiring a shift from traditional drug sales to comprehensive health services, enhancing professional services, health promotion, and emergency supply capabilities [1].

Core Viewpoint - The new policy document issued by the Ministry of Commerce and nine other departments aims to enhance the role of retail pharmacies in China, transforming them into "health stations" that provide professional services, health promotion, and emergency supply functions [1][2]. Group 1: Empowerment - The policy allows retail pharmacy chains to establish their own pharmaceutical service platforms, enabling licensed pharmacists to conduct remote prescription reviews and provide medication guidance [1]. - Retail pharmacies can now offer reimbursement for medications purchased with hospital prescriptions, aligning with the same medical insurance policies as grassroots medical institutions [1]. - The document encourages retail pharmacies to participate in centralized drug procurement to lower drug prices and enhance their bargaining power through collective purchasing [1]. Group 2: Quality Improvement - The policy promotes the optimization of the drug business license application process and encourages the sale of innovative drugs and reference preparations through retail pharmacies to improve drug supply quality and service capabilities [2]. Group 3: Accountability - The document emphasizes the need for retail pharmacies to strengthen emergency services and encourages large pharmacy chains to establish dynamic demand forecasting and low inventory warning mechanisms [2]. - Retail pharmacies are encouraged to provide care measures for outdoor workers, such as temporary rest areas and hydration, and to collaborate with community committees and medical institutions to offer health care services for the elderly, disabled, and children [2].

转自：成都日报锦观 九部门： 促进药品零售行业高质量发展 在应急服务方面，明确鼓励大型连锁药店健全库存监测和预警机制，发挥药品供应"哨点"作用。针对行 业结构和市场秩序，《意见》支持零售药店依法开展兼并重组，推动批零一体化发展，降低流通成本。 据央视财经 在完善药事服务方面，《意见》提出要提升药学服务能力，鼓励药品零售企业配备执业药师团队，允许 药品零售连锁企业总部自建药学服务平台，依法开展远程处方审核和合理用药指导。同时，持续推进处 方外配和电子处方流转，优化医保结算和门诊统筹政策，让群众在家门口买药更加便捷、高效。 围绕创新健康服务，《意见》支持零售药店拓展用药指导、健康咨询等服务功能，鼓励与社区、医疗机 构联动，提供适老、助残等健康照护服务。顺应数字化趋势，推动互联网医院与实体药店融合发展。 1月22日，商务部、国家发展改革委等九部门联合发布《关于促进药品零售行业高质量发展的意见》。 《意见》围绕完善药事服务、强化应急保供等五方面，提出18项具体举措。 药品零售行业是我国医药卫生体系的重要组成部分，直接关系群众用药安全和健康获得感。此次出台的 政策明确，坚持政府引导与市场主导相结合，加快把零售药店打造成 ...

例如，本次《意见》提出要优化定点零售药店门诊统筹服务，明确参保人员凭定点医药机构处方在定点 零售药店购买医保目录内药品发生的费用可由医保基金按规定支付。定点零售药店门诊统筹起付标准、 支付比例、最高支付限额等，可执行本统筹地区基层医疗机构相同的医保待遇政策。 在行业发展层面，《意见》提出支持零售药店兼并重组、鼓励批零一体化发展、优化药品营销体系等举 措，从而推动实现行业供应链效率提升。 具体来看，《意见》鼓励药品零售企业依法开展横向并购与重组。鼓励药品批发企业依法通过兼并重组 整合供应链与零售终端，推动批零一体化发展，实现仓储物流资源共用、质量管理体系协同及全流程信 息追溯，提升供应链效率，有效降低运营成本。在药品营销方面，倡导医药生产企业与全国或区域大型 医药流通企业深度合作，以市场为导向规范药品购、销价格体系，促进药品零售行业跨省、跨地区公平 竞争，引导零售药品价格保持合理水平。 （文章来源：证券时报） 1月22日，商务部等九部门发布了《关于促进药品零售行业高质量发展的意见》（以下简称《意 见》），从完善药事服务、创新健康服务、强化应急服务、优化行业结构、规范行业秩序等方面提出18 条具体举措，推动药品零 ...

【导读】商务部等9部门发布关于促进药品零售行业高质量发展的意见 1月22日，商务部、国家发展改革委、工业和信息化部、国家卫生健康委、市场监管总局、金融监管总局、国家医保局、国家中医药局、国家药监局发布 《关于促进药品零售行业高质量发展的意见》（以下简称《意见》）。 为推动药品零售行业专业化、集约化、数字化、规范化发展，从"药品销售终端"转型为服务人民医药健康需求的"健康驿站"，《意见》围绕完善药事服 务、创新健康服务、强化应急服务、优化行业结构、规范行业秩序等五个方面提出18项具体举措。 基金君整理要点如下： 全文如下： 商务部等9部门关于促进药品零售行业高质量发展的意见 药品零售行业是国家医药卫生事业的重要组成部分，关系人民健康和生命安全。为贯彻落实党中央、国务院有关决策部署，强化药品零售行业专业服务、 健康促进、应急保供等功能，打造更好服务人民医药健康需求的"健康驿站"，现提出如下意见： 一、总体要求 坚持以习近平新时代中国特色社会主义思想为指导，全面贯彻党的二十大和二十届历次全会精神，坚持政府引导与市场主导相结合、创新驱动与规范发展 并重，积极优化政策环境，培育和壮大经营主体，推动药品零售行业专业化、集 ...

1月22日，据商务部官网消息，商务部等9部门印发《关于促进药品零售行业高质量发展的意见》（以下 简称《意见》），围绕完善药事服务、强化应急保供等5个方面，提出了18项具体举措。 值得注意的是，《意见》指出，支持零售药店进行兼并重组。鼓励药品零售企业依法开展横向并购与重 组。鼓励各地优化营商环境，对于被整合的连锁或单体药店，优化《药品经营许可证》申请核发流程。 涉及医保资质变更的，允许原医保资质继续存续和使用，新医保资质正式开通后，注销原医保资质。 商务部消费促进司有关负责人就《意见》进行解读时表示，当前，我国医药零售行业正处于创新转型的 关键时期，需要推动其从传统药品销售向综合性健康服务转型，强化专业服务、健康促进与应急保供等 功能，将其打造成贴近社区、服务百姓的"健康驿站"，提升全民健康保障体系的韧性与可及性。 《意见》提出，丰富药品零售业态。鼓励开展与中药零售相关的中医药健康咨询指导、中医药文化体验 等服务。支持老字号药品零售企业创新发展。结合一刻钟便民生活圈建设，鼓励品牌连锁药店进社区、 进乡镇，鼓励商超、便利店等日常消费场所依法依规销售符合监管要求的药品。 《意见》指出，引导药品零售企业提升药品经营管 ...

Core Viewpoint - The joint opinion issued by nine departments aims to promote high-quality development in the pharmaceutical retail industry, transforming drugstores into "health stations" that provide professional services, health promotion, and emergency supply support [2][3]. Group 1: Policy Objectives - The document is the first dedicated policy for the pharmaceutical retail sector in China, focusing on enhancing the industry's service capabilities and meeting public health needs [2][4]. - The pharmaceutical retail market in China has expanded, with sales increasing from 2.41 trillion yuan in 2020 to an expected 2.95 trillion yuan in 2024 [4]. Group 2: Key Measures - The opinion outlines 18 measures to support drugstores in improving pharmaceutical service capabilities, optimizing purchasing experiences, participating in centralized drug procurement, and establishing payment security systems [3][4]. - Drug retail chains are allowed to establish their own pharmaceutical service platforms, enabling licensed pharmacists to provide remote prescription reviews and medication guidance [4]. Group 3: Quality Improvement - The opinion encourages the optimization of the drug business license application process and promotes the sale of innovative drugs and reference preparations through retail channels [5]. - Support for mergers and acquisitions among retail pharmacies and the integration of wholesale and retail operations is emphasized to enhance supply chain efficiency and promote fair competition [5]. Group 4: Accountability and Community Engagement - The document stresses the importance of emergency services in retail pharmacies, encouraging large chains to establish dynamic demand forecasting and low inventory warning systems [5][6]. - Retail pharmacies are encouraged to provide care measures for outdoor workers and collaborate with community committees and medical institutions to offer health care services [5][7]. Group 5: Industry Competition - The opinion promotes fair competition within the industry, advocating for collaboration between pharmaceutical manufacturers and large distribution companies to regulate drug pricing and maintain reasonable retail prices [6][7].

Core Viewpoint - The article discusses the joint issuance of guidelines by the Ministry of Commerce and nine other departments to promote high-quality development in the pharmaceutical retail industry, focusing on enhancing services, innovation, emergency support, industry structure optimization, and regulatory compliance [1][3][4]. Group 1: Enhancing Pharmaceutical Services - The guidelines aim to improve pharmaceutical services by supporting pharmacies to enhance their pharmaceutical service capabilities, optimize purchasing experiences, participate in centralized drug procurement, and establish payment security systems [4][6]. - Pharmacies are encouraged to equip themselves with licensed pharmacists and health consultants, and to provide remote pharmaceutical services [6][7]. - The guidelines promote the flow of prescriptions and enhance the purchasing experience through improved electronic prescription systems and collaboration between medical institutions and pharmacies [6][7]. Group 2: Innovating Health Services - Pharmacies are encouraged to expand health service functions, including medication guidance and health consultations, and to engage in health education activities [9]. - The guidelines support the establishment of remote health consultation centers in pharmacies, particularly in underserved areas, and promote the use of technology for health service upgrades [9][10]. - There is an emphasis on diversifying retail pharmacy formats and enhancing the shopping experience for consumers [9][10]. Group 3: Strengthening Emergency Services - The guidelines call for pharmacies to enhance their service capabilities in emergency supply situations and to participate in drug market monitoring [11][12]. - Pharmacies are encouraged to provide public health education and support during emergencies, such as pandemics or disasters [11][12]. Group 4: Optimizing Industry Structure - The guidelines support mergers and acquisitions among retail pharmacies to improve industry concentration and efficiency [12][13]. - There is a push for integrated development between wholesale and retail sectors to enhance supply chain efficiency and reduce operational costs [13][14]. - The guidelines advocate for a fair pricing system in the pharmaceutical retail market to promote healthy competition [13][14]. Group 5: Regulating Industry Order - The guidelines propose the development of smart regulation to enhance compliance and monitoring within the pharmaceutical retail sector [14]. - There is a focus on promoting fair competition and preventing illegal practices in online and offline pharmaceutical sales [14]. - The guidelines encourage industry self-discipline and the establishment of industry standards to ensure responsible business practices [14].

1月22日，商务部、国家发展改革委、国家医保局等九部门联合印发《关于促进药品零售行业高质量发 展的意见》，《意见》围绕完善药事服务、创新健康服务、强化应急服务、优化行业结构、规范行业秩 序五大方面推出18项具体举措，明确推动药品零售行业向专业化、集约化、数字化、规范化发展，将零 售药店打造成为服务人民医药健康需求的"健康驿站"。 完善药事服务体系，筑牢专业服务根基 药事服务是药品零售行业的核心职能，此次《意见》从多维度完善药事服务能力，推动行业从 "药品销 售终端" 向 "健康服务枢纽" 转型。在药学服务能力提升上，《意见》鼓励药品零售企业配备执业药师 团队与健康顾问，支持连锁企业总部自建药学服务平台开展远程药事服务，同时明确不得降低执业药师 驻店配备要求，部分地方还将实施执业药师继续教育免费或补助政策，从人才层面夯实专业服务基础。 处方流转机制的完善将进一步提升购药体验。政策推动医疗机构加强外配处方服务，完善外配处方流转 机制，鼓励符合监管要求的实体医疗机构、互联网医院与药品零售企业依托电子处方流转平台进行处方 流转。这将打通医疗机构与零售药店之间的信息壁垒，让患者享受更加便捷的购药服务。 医保方面，定点零 ...